Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 28, 2015 9:02 PM ET


Company Overview of Enanta Pharmaceuticals, Inc.

Key Executives for Enanta Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Jay R. Luly Ph.D.38 RelationshipsChief Executive Officer, President and Director59
Paul J. Mellett Jr.No RelationshipsChief Financial Officer and Senior Vice President of Finance & Administration60
Nathalie Adda M.D.No RelationshipsChief Medical Officer and Senior Vice President49
Nathaniel S. Gardiner J.D.No RelationshipsSenior Vice President, General Counsel and Secretary61
Timothy D. Ocain Ph.D.10 RelationshipsSenior Vice President of New Product Strategy and Development57

Enanta Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Jay R. Luly Ph.D. 38 RelationshipsEnanta Pharmaceuticals, Inc.59
Terry C. Vance 28 RelationshipsSaints Capital57
Stephen Buckley Jr. 23 RelationshipsEnanta Pharmaceuticals, Inc.65
Bruce L. A. Carter Ph.D. 182 RelationshipsXencor, Inc.72
Ernst-Günter Afting Ph.D., M.D. 25 RelationshipsEnanta Pharmaceuticals, Inc.71
View All Board Members

Enanta Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Jr.Stephen Buckley23 Relationships3 Executives
Compensation Committee Ph.D.Bruce L. A. Carter182 Relationships3 Executives
Nominating Committee Terry C. Vance28 Relationships5 Executives
Corporate Governance Committee Terry C. Vance28 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$751.8K
Compensation as of Fiscal Year 2014
Enanta Pharmaceuticals, Inc. CEO Compensation
Industry Average


Procter & Gamble Co. Announces Executive Changes
November 20, 2015 11:57 PM ET
Pental Ltd Announces Board Appointments
November 19, 2015 9:45 PM ET
Hipolin Ltd Announces Reconstitution of Audit, Nomination and Remuneration Committee
November 06, 2015 12:30 PM ET
Church & Dwight Co. Inc. Announces Management Changes
October 29, 2015 8:38 PM ET
SCA Appoints Anna Sävinger-Åslund as its new Senior Vice President, Group Function Human Resources, Effective from November 1, 2015
October 29, 2015 6:45 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Enanta Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at